Janssen Korea has been approved by the MFDS for Pharmaceutical Consignment Permission for Manufacturing Business. This can be interpreted as part of the withdrawal of the Hyangnam plant. If Janssen Korea completely withdraws its Hyangnam plant, there will be no Janssen Korea plant facilities in Korea.

The MFDS approved the "Manufacturing Business" of Janssen Korea as of the 26th. Drug consignment Manufacturing Business does not have domestic production facilities, but is granted to companies that are licensed for manufacturing items through consignment manufacturers. So far, 11 companies have received it. Among the nation's history, GL Pharm Tech , Corepharmbio, Crystalgenimics, Gunkang, Woosung,iN Ther